There was no significant difference in the percentage of patients with a 1st stroke compared to recurrent (2nd) stroke in relation to the use of statins (95% vs 87%), ACE-inhibitors (52% vs 58%), Angiotensin II receptor blockers (6% vs 13%), Beta blockers (10% vs 29%), calcium channels blockers (16% vs 26%), aspirin (83% vs 77%) and clopidogrel (58% vs 45%) (Table 2). Here, ACE is linked to stroke disorder.